Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Innovative Facility for Isotope GENeration with Efficient Ion Accelerator

Project description

Advanced accelerator technology for nuclear medicine and molecular imaging

Access to advanced nuclear medicine and molecular imaging is critical for modern healthcare. However, current radioisotope production methods face environmental concerns and provide only a limited range of isotopes, while demand for novel isotopes in diagnostics and therapy is steadily increasing. The EU-funded IFIGENEIA project plans to design a cutting-edge facility based on linear accelerator (LINAC) technology, offering a sustainable, flexible and environmentally friendly alternative. LINACs can produce a broader spectrum of radioisotopes owing to their tuneable energy, targets and currents. IFIGENEIA will establish interconnected hubs in Greece, Cyprus and Slovenia, serving as innovation centres for isotope development and validation. This should help foster cross-border collaboration, and advance diagnostics, therapy and theranostics.

Objective

The IFIGENEIA Excellence Hub aspires to introduce, develop and deliver the complete design study and the precise business plan for the implementation in Europe of the LINear ACcelerator (LINAC) technology in radiation therapy, diagnostic and theranostic procedures. Linear Accelerator technologies offer a unique, compact, cost-effective, and environmentally friendly solution for sustainable production, management, accessibility, and promotion of nuclear medicine and molecular imaging technologies.
Unlike current radioisotope production methods, mostly reliant on older nuclear reactors using highly enriched uranium with associated concerns about global availability, safety, and environmental issues, or on cyclotrons limited to a narrow range of radioisotopes, LINACs enable the production of a broader range due to their tunability in energy, targets, and currents. The IFIGENEIA Excellence Hub aims to create the complete design and implementation study for a cutting-edge LINAC facility in the Balkans, by creating in Greece, Slovenia and Cyprus Excellence Hubs dedicated to developing and implement a LINAC-based facility, capable of producing a diverse range of marketable radioisotopes. Interconnected Hubs will collaboratively pursue national and international partnerships to achieve shared strategic goals and improve value chains. The project focuses on a cross-border R&I strategy, an investment plan, and implementing innovative products and services across the hubs. Each Hub will unite regional stakeholders in healthcare, culture, academia, businesses, public sectors, and societal actors, working toward sustainable nuclear medicine and culture in their regions. IFIGENEIA aims to incubate future excellence hubs in the West Balkan region and will provide mentoring to West Balkan countries in the current project.
In collaboration with esteemed research centers, IFIGENEIA can create a lasting technological and business framework for nuclear medicine in Europe.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-WIDERA-2023-ACCESS-07

See all projects funded under this call

Coordinator

ARISTOTELIO PANEPISTIMIO THESSALONIKIS
Net EU contribution
€ 829 266,25
Address
KEDEA BUILDING, TRITIS SEPTEMVRIOU, ARISTOTLE UNIVERSITY CAMPUS
546 36 THESSALONIKI
Greece
Region
Βόρεια Ελλάδα Κεντρική Μακεδονία Θεσσαλονίκη
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 829 266,25

Participants (21)